Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12109296 Peptide exhibiting wrinkle-improving activity and uses thereof

Patent 12109296 was granted and assigned to Caregen Co., Ltd. on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Caregen Co., Ltd.

Date Filed

April 28, 2023

Date of Patent

October 8, 2024

Patent Applicant

Caregen Co., Ltd.

Patent Application Number

18308908

Patent Citations

‌

US Patent 11104704 Peptide having cytoprotective effect against environmental pollutant and use thereof

‌

US Patent 11103436 Peptide exhibiting wrinkle-improving activity and uses thereof

‌

US Patent 8343501 Bispecific EGFR/IGFIR binding molecules

‌

US Patent 8344211 Plant nucleotide sequences and corresponding polypeptides

‌

US Patent 9884910 Anti-PDGF-C antibodies

‌

US Patent 10047125 Peptide having activity to improve skin condition and use thereof

‌

US Patent 10676507 Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatment

Patent Inventor Names

Eung Ji Lee

Yong Ji Chung

Eun Mi Kim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12109296

Patent Primary Examiner

CPC Code

Find more entities like US Patent 12109296 Peptide exhibiting wrinkle-improving activity and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.